Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synera in Shoulder Impingement Syndrome
NCT01055444Phase 2Completed
- Sponsor
- ZARS Pharmaceuticals
- Start
- Mar 2010
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tetracaine in shoulder impingement syndrome (SIS), sponsored by ZARS Pharmaceuticals. Started Mar 2010; status: completed.
02
Drugs
tetracaine
03
Conditions
shoulder impingement syndrome (SIS)
Beyond the preview
Go deeper on NCT01055444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01055444.